We are live on ! Find out more
NVO

Novo Nordisk
NVO

644 hedge funds and large institutions have $9.5B invested in Novo Nordisk in 2020 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 165 increasing their positions, 281 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more funds holding in top 10

Funds holding in top 10: 13 → 21 (+8)

18% more call options, than puts

Call options by funds: $30.8M | Put options by funds: $26.1M

16% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 61

1% more funds holding

Funds holding: 640 → 644 (+4)

4% less capital invested

Capital invested by funds: $9.9B → $9.5B (-$397M)

1.41% less ownership

Funds ownership: 18.37% → 16.96% (-1.4%)

41% less repeat investments, than reductions

Existing positions increased: 165 | Existing positions reduced: 281

Holders
644
Holders Change
+4
Holders Change %
+0.63%
% of All Funds
14.19%
Holding in Top 10
21
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+61.54%
% of All Funds
0.46%
New
71
Increased
165
Reduced
281
Closed
61
Calls
$30.8M
Puts
$26.1M
Net Calls
+$4.79M
Net Calls Change
-$59.9M

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$97.9M
2
Jane Street
Jane Street
New York
+$29.1M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$21.2M
4
OMC
Old Mission Capital
Illinois
+$17.3M
5
Capital International Investors
Capital International Investors
California
+$16.8M

Top Sellers

1
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$317M
2
SGA
Sustainable Growth Advisers
Connecticut
-$135M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$62.2M
4
AAMU
Amundi Asset Management US
Massachusetts
-$56.6M
5
Bank of America
Bank of America
North Carolina
-$54.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
26
Jennison Associates
New York
$69.4M +$1.21M +40,552 +2%
SC
27
Saturna Capital
Washington
$68.5M +$51K +1,714 +0.1%
Envestnet Asset Management
28
Envestnet Asset Management
Illinois
$67.8M +$4.47M +150,230 +7%
MG
29
Markel Group
Virginia
$64.7M – – –
Bank of New York Mellon
30
Bank of New York Mellon
New York
$63.6M +$344K +11,564 +0.6%
Goldman Sachs
31
Goldman Sachs
New York
$57.8M -$3.91M -131,252 -6%
Morgan Stanley
32
Morgan Stanley
New York
$49.1M +$1.52M +50,948 +3%
UCFA
33
United Capital Financial Advisors
Texas
$48.4M +$2.58M +86,508 +5%
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$45M -$54.1K -1,818 -0.1%
AAMU
35
Amundi Asset Management US
Massachusetts
$40.9M -$56.6M -1,901,444 -58%
First Trust Advisors
36
First Trust Advisors
Illinois
$40.3M -$9.86M -331,248 -20%
Baird Financial Group
37
Baird Financial Group
Wisconsin
$38.3M -$5.07M -170,300 -12%
SFM
38
Sphera Funds Management
Israel
$34.7M -$3.81M -128,000 -10%
Jane Street
39
Jane Street
New York
$29.7M +$29.1M +977,592 +9,851%
Truist Financial
40
Truist Financial
North Carolina
$29.7M +$2.51M +84,164 +9%
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$28.1M -$13.7M -459,528 -33%
JP Morgan Chase
42
JP Morgan Chase
New York
$28M -$2.47M -83,028 -8%
PNC Financial Services Group
43
PNC Financial Services Group
Pennsylvania
$27.7M -$43.8K -1,472 -0.2%
Connor, Clark & Lunn Investment Management (CC&L)
44
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$27.6M -$8.06M -270,800 -23%
Fidelity Investments
45
Fidelity Investments
Massachusetts
$27.2M -$1.49M -49,920 -5%
OMC
46
Old Mission Capital
Illinois
$27M +$17.3M +579,776 +183%
AIA
47
Avalon Investment & Advisory
Texas
$26M +$464K +15,586 +2%
UBS Group
48
UBS Group
Switzerland
$25.6M -$847K -28,442 -3%
Stifel Financial
49
Stifel Financial
Missouri
$24.8M +$5.92M +198,788 +32%
Adage Capital Partners
50
Adage Capital Partners
Massachusetts
$24.1M -$23.8M -800,000 -50%
1
2
3 4 5

NVO Hedge Fund Activity: Q1 2020 in Review

644 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2020, worth a combined $9.5B — down 4% from $9.9B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new NVO positions and 61 closed out — a net gain of 10 holders — while 165 added to existing stakes and 281 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $97.9M. The largest seller was Loomis, Sayles & Company, cutting an estimated $317M.

  • 644 institutional investors held Novo Nordisk (NVO) as of Q1 2020, up from 640 in Q4 2019.
  • Funds reported $9.5B of Novo Nordisk stock for Q1 2020, down 4% quarter-over-quarter.
  • 71 funds opened new Novo Nordisk positions in Q1 2020 and 61 closed out, a net change of +10 holders.
  • The largest Novo Nordisk buyer in Q1 2020 was Renaissance Technologies, an estimated $97.9M added.
  • The largest Novo Nordisk seller in Q1 2020 was Loomis, Sayles & Company, an estimated $317M sold.

Based on aggregated 13F filings for Q1 2020.